ID
25735
Description
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced
Keywords
Versions (1)
- 9/16/17 9/16/17 -
Copyright Holder
glaxoSmithKline
Uploaded on
September 16, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Description
Study medication oral
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C1527415
Description
Dosing day
Data type
partialDate
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439228
Description
Session hour
Data type
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439227
Description
Session minute
Data type
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439232
Description
Start dose date
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0178602
Description
Start dose time
Data type
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0178602
Description
Dose amount
Data type
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1264637
Description
Dose unit
Data type
text
Alias
- UMLS CUI [1]
- C0869039
Description
Dose form
Data type
text
Alias
- UMLS CUI [1]
- C0013058
Description
Dose route
Data type
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0679006
Description
Study Medication IV
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C1522726
Description
Dosing day
Data type
partialDate
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439228
Description
Session hour
Data type
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439227
Description
Session minute
Data type
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439232
Description
Start dose date
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0178602
Description
Start dose time
Data type
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0178602
Description
End Dose Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0178602
Description
End Dose Time
Data type
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0178602
Description
Start Dose Volume
Data type
text
Alias
- UMLS CUI [1,1]
- C0449468
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0439659
Description
End Dose Volume
Data type
text
Alias
- UMLS CUI [1,1]
- C0449468
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0444930
Description
Dose amount
Data type
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1264637
Description
Dose unit
Data type
text
Alias
- UMLS CUI [1]
- C0869039
Description
Dose form
Data type
text
Alias
- UMLS CUI [1]
- C0013058
Description
Dose route
Data type
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0679006
Similar models
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
C0679006 (UMLS CUI-2)
C0679006 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C1527415 (UMLS CUI-3)
C0439228 (UMLS CUI [1,2])
C0439227 (UMLS CUI [1,2])
C0439232 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C1264637 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C1522726 (UMLS CUI-3)
C0439228 (UMLS CUI [1,2])
C0439227 (UMLS CUI [1,2])
C0439232 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0439659 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,3])
C1264637 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])